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in 2006. We computed a MDMS (range 0–100) based on 
the sex-specific results of a multicorrespondence analysis 
(MCA). We then used Cox regression models to assess 
the predictive validity of this MDMS on incident sickness 
absence (SA) episodes.
Results Two dimensions in the MCA explained about 
80 % of the variability in both sexes: (1) chronic cardiovas-
cular conditions and health behaviors, and (2) pain symp-
toms, in addition to sleep disturbances in women. More 
men than women had at least one condition (40 vs 15 %) 
and two or more (i.e., multimorbidity) (12 vs 2 %). The 
MDMS among those with multimorbidity ranged from 16.8 
(SD 2.4) to 51.7 (SD 9.9) in men and 18.5 (SD 5.8) to 43.8 
(SD 7.8) in women. We found that the greater the number 
of health conditions, the higher the risk of SA. A higher 
MDMS was also a risk factor for incident SA, even after 
adjusting for prior SA and other covariates. In women, this 
trend was less evident.
Conclusions A score incorporating chronic health condi-
tions, behaviors, and symptoms provides a more holistic 
approach to multimorbidity and may be useful for defining 
health status in working populations and for predicting key 
occupational outcomes.
Keywords Health conditions · Longitudinal · 
Occupational health · Sick leave
Background
As the world’s population ages, the prevalence of mul-
tiple chronic and non-chronic health-related conditions 
is increasing (Fortin et al. 2007). One in four adults has 
at least two chronic conditions, more than half of older 
adults has three or more, and most primary care patients 
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lations. We propose a multidimensional multimorbidity 
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sumably healthier, working populations.
Methods Cross-sectional study of 372,370 Spanish work-
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have coexisting conditions (Boyd et al. 2007). And, while 
we live longer as a result of advances in clinical care and 
public health policies, we are also working longer due to 
increases in the retirement age and living with coexist-
ing health conditions and unhealthy behaviors affecting 
not only our quality of life, but also our ability to work, 
employability, and disability (Robson et al. 2001; Fortin 
et al. 2004; Bevan et al. 2009).
The coexistence of two or more health conditions has 
been, for some time, referred to indistinctly as comorbidity, 
i.e., the occurrence of any additional condition affecting the 
course and treatment of a primary condition (Feinstein 1970; 
Valderas et al. 2009), or multimorbidity, i.e., the occurrence 
of two or more chronic conditions with none considered 
the primary condition (van den Akker et al. 1998). During 
the last decade, rather than focusing on single pathologies, 
patterns of medical care are evolving toward a more holis-
tic approach with increasing interest in the epidemiology of 
multimorbidity (Fortin et al. 2007; Starfield 2011a).
To date, however, indicators of multimorbidity have 
largely been constructed on the basis of chronic health con-
ditions or common diseases and mainly focused on patient 
and/or older populations. The applicability of these indi-
cators of multimorbidity to other younger and healthier 
populations, such as the working population (Li and Sung 
1999), has not been well studied. In the workforce, how-
ever, chronic diseases might be not as prevalent as in com-
monly studied populations, while certain unhealthy behav-
iors that are risk factors for later development of chronic 
health conditions are (Miller 2011). Health risk factors 
raise the probability of adverse health outcomes (i.e., mor-
tality, disability and chronic conditions) (WHO 2009), but 
whether those risk factors impact the clustering of chronic 
conditions is an incipient idea to be further explored. It is 
expected that, by 2020, the proportion of the workforce age 
50 and over will increase substantially, as will the num-
ber and range of morbidities (Great Britain. Department 
for Work and Pensions 2009). Identifying and improving 
health behaviors earlier could reduce the onset of future 
morbidity, leading to better health status and lower disease 
burden in later ages.
The adverse impact of multiple chronic conditions on 
occupational outcomes, such as sickness absence (SA) or 
work ability has been previously described (Koolhaas et al. 
2014; Casimirri et al. 2014). However, individuals, usually 
older workers, were grouped based simply on the presence 
or absence, number, or combinations of chronic conditions 
(Kessler et al. 2001; Collins et al. 2005).
Regarding its measurement, there is a lack of uniform-
ity in the operationalization of multimorbidity (Fortin 
et al. 2012), with great heterogeneity both in the selection 
(i.e., frequently, chronic conditions are selected based on 
the highest prevalence and/or mortality rates in the study 
population (Diederichs et al. 2011) which varies by default) 
and number (i.e., coexisting diseases may be simply 
counted, ranging from 6 to over 100) of chronic conditions 
chosen (Huntley et al. 2012). In addition, multimorbidity 
indices are usually intended to predict specific outcomes.
Some calculate risk of death based on age and mortal-
ity rates of comorbid conditions (e.g., Charlson Comorbid-
ity Index) (D’Hoore et al. 1996) or hospitalization rates 
based on pharmacy data (e.g., Chronic Disease Score) (Von 
Korff et al. 1992), while others calculate physical impair-
ment (e.g., Functional Comorbidity Index) (Groll et al. 
2005) or health status (e.g., KoMo score) (Glattacker et al. 
2007) based on disease severity. Standardized indices may 
facilitate comparability, but the focus on specific prede-
fined diseases and outcomes limits their generalizability 
and assumes these diseases and related predictive effects 
are the ones of interest, disregarding the potential impact of 
multimorbidity on other outcomes. In addition, these indi-
ces have a priori assigned weighting schemes that adjusted 
for severity of condition but which may need to be updated, 
as the index–outcome relationship may change over time. 
Given all the above, while these indices may be useful for 
the specific outcome they are designed to capture, they may 
be of limited use to reflect the effect of multimorbidity on a 
given population as a whole.
To overcome these restraints, we propose calculating a 
multidimensional multimorbidity score (MDMS) based on 
examining the relationship between health-related condi-
tions, available in many population databases, without ini-
tially considering its impact on a specific outcome. Further, 
individuals living with multimorbidity may cope well and 
without any intervention, whereas others may not, due to 
other health-related factors. To better reflect this complex 
scope, the common clinical concept of multimorbidity may 
be expanded by going beyond chronic diseases, examin-
ing how they overlap at specific points in time with other 
health-related conditions, risk factors, health behaviors, or 
even psychological distress (Mercer et al. 2009). To our 
knowledge, few studies have looked into the clustering of 
chronic health conditions (Prados-Torres et al. 2014; Garin 
et al. 2014), even fewer in groups healthier than the general 
population, such as the working population (Holden et al. 
2011), and none including other health-related conditions 
beyond chronic diseases. Such a score could be useful for 
determining the burden and distribution of multimorbidity 
in a working population, and by extension its health status, 
as well as to predict target occupational outcomes.
Methods
The study population consisted of 372,370 workers regis-
tered with the Spanish social security system and covered 
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by one of the largest state health mutual insurance com-
panies (mutua). These workers underwent a standard-
ized medical evaluation in 2006 by a subsidiary company 
focused on illness and injury prevention (“prevention ser-
vice”). The study proposal was reviewed and approved 
by the Clinical Research Ethics Committee of the Parc de 
Salut Mar in Barcelona, and an agreement assuring par-
ticipant confidentiality was signed by all stakeholders. 
Data were treated confidentially in accordance with cur-
rent Spanish legislation on data protection. All data were 
de-identified before being delivered to the research team. 
All participants gave informed consent for their data to be 
included in the study.
Each evaluation was performed by an occupational phy-
sician, and included completion of a uniform questionnaire 
and measurement of body mass index (BMI) as part of the 
physical examination. The questionnaire included demo-
graphic, labor, and clinical variables and had been devel-
oped by the mutua’s occupational health service personnel 
(technicians, researchers, and occupational physicians) for 
general health surveillance purposes.
Basic socio-demographic and labor characteristics 
included sex (female/male), age (grouped as <25, 25–34, 
35–44, 45–54, 55–65, >65 years), and occupation coded 
using the Spanish National Classification of Occupation 
(CNO93) and grouped by occupational social class (Regi-
dor 2001) [I–management (≥10 employees), II–manage-
ment (<10 employees), IIIa–administrative, IIIc–manual 
workers’ supervisor, IVa–skilled manual workers, IVb–
semi-skilled manual workers, and V–unskilled workers]. 
The questionnaire collected data on prior diagnoses of 
chronic conditions (hypertension, hyperlipidemia, diabetes, 
venous thrombosis, coronary artery disease, cerebrovas-
cular disease, and/or peripheral vascular disease), health 
behaviors (tobacco and alcohol consumption), and selected 
symptoms (headache, fatigue, sleep disturbances, neck 
and low back pain). Questions on chronic conditions and 
symptoms were formulated as Yes or No, whereas sleep 
disturbances were categorized as “able to sleep continu-
ously more than 6 h,” “sleep is disrupted during the night,” 
and “sleep is disrupted in the early morning.” Tobacco use 
was classified as never, current or ex-smoker, and alcohol 
consumption as never drinker, occasional (less than once a 
week), weekend, daily moderate [<140 g of alcohol weekly, 
daily high (equal or more than 140 g of alcohol weekly)], 
and former drinker.
Construction of the MDMS was developed in two steps. 
First, we ran a multiple correspondence analysis (MCA) 
with the joint method (JCA) including the eight previously 
described chronic conditions; the five symptoms, tobacco 
and alcohol consumption. The MCA is a data analysis tech-
nique used to identify patterns of relationships between 
more than two sets of categorical variables by using 
multiway cross-tabulation (Abdi and Valentin 2007). Two 
key parameters are provided by the MCA: inertia (i.e., per-
centage of explained variance for each dimension or axis 
obtained) and the contribution of the variables’ categories 
(i.e., absolute, or the inertia relative to the principal inertia 
on an axis; and relative, or the inertia relative to the inertia 
of a category) (Greenacre 2003). The addition of all abso-
lute contributions is 1 for a given dimension, which allows 
the identification of the most relevant categories. The closer 
the relative contribution of a given category to 1, the bet-
ter is it represented within the dimension. Those catego-
ries contributing the most to the inertia of each dimension 
(absolute contribution) and those better represented within 
the dimension (i.e., relative contribution closer to 1) will be 
considered relevant. The JCA method of the MCA corrects 
the percentages of the explained variance obtained with 
MCA and can be interpreted as a factor analytic model or a 
generalization of principal component analysis (Greenacre 
1984).
All analyses were conducted for men and women sepa-
rately. While the variables, obtained from the standardized 
questionnaire, initially included in the MCA were the same 
for men and women, we conducted sex-specific analysis 
based on the following considerations: (1) since males rep-
resented 70 % of the sample, calculating sex-specific mul-
timorbidity scores helped avoid overall effect attributions; 
(2) the prevalence of specific chronic health conditions was 
different for both sexes, which in turn would lead to dif-
ferent multimorbidity prevalence as the MDMS is based 
on relationships among health-related conditions; and (3) 
the combination of significant health-related conditions 
accounting for the two dimensions obtained, in addition to 
their absolute contributions (weights), differed by sex.
In a second step, we developed an algorithm based on 
the contributions of the categories for each of the variables 
weighting significantly in the dimensions obtained from the 
JCA. Of all 15 variables, with 37 categories overall, those 
showing an absolute contribution equal to or greater than 
the mean absolute contribution of all variables included in 
the JCA (i.e., 1/15) were considered in the calculation of 
the dimension score. Within these variables, we selected 
those categories with an absolute contribution equal to or 
greater than the mean absolute contribution of the corre-
sponding variable, and a relative contribution ≥0.3. The 
final MDMS was the sum of the value for the weighted 
absolute contributions (i.e., dimensions scores x inertia) 
of each dimension obtained. The algorithm applied was 
MDMS = [(ScD1 + ScD2)/max ScD] × 100 = {[(Σ 
AbsC × InertiaD1) + (Σ AbsC × InertiaD2)]/max 
ScD} × 100, where multidimensional multimorbidity score 
is the MDMS; Sc is the score for each dimension; D1 and 
D2 are the first and second dimensions, respectively; AbsC 
refers to the categories’ absolute contribution, and max ScD 
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is the maximum score for each sex. The MDMS ranged 
from zero (no multimorbidity) to 100 (high multimorbid-
ity). For example, a man with obesity (AbsC = 0.065), 
diabetes (AbsC = 0.081), and headache (AbsC = 0.072) 
would have a low MDMS level of 18.4, calculated as fol-
lows: [(0.065 + 0.081) × 0.65 + (0.072 × 0.18)]/0.586} 
× 100, where 0.586 is the max ScD calculated for men.
Additionally, we calculated two alternative MDMSs by 
including: (a) chronic conditions alone, and (b) chronic 
conditions and symptoms, in order to compare its dis-
tribution with our proposed MDMS. Individuals were 
categorized with none, one, two, and more than two self-
reported health conditions. Multimorbidity was consid-
ered present when there were at least two co-occurring 
health conditions. Among persons with multimorbidity, the 
MDMS was grouped into tertiles (low, medium, and high 
multimorbidity).
In a final step, the MDMS, together with SA occurring 
in the 2 years prior to the 2006 medical evaluation, were 
used to fit Cox models, adjusted by age and occupational 
social class, to test its ability to predict new first SA epi-
sodes, expressed as the crude (HRc) and adjusted (HRa) 
hazard ratios and corresponding 95 % confidence intervals 
(95 % CI). Information on prior SA episodes, occurring 
during the 2 years prior to medical evaluation, incident SA 
and other socio-demographic variables, were obtained from 
the social security data system, which is the official registry 
for SA episodes in Spain (Benavides et al. 2014).
The final sample for the survival models (236,500 men 
and 91,440 women) excluded individuals on sick leave dur-
ing the medical evaluation, those lacking insurance cover-
age before the medical evaluation or the new SA episode, 
and those with missing data on key variables (Fig. 1). Sta-
tistical analyses were performed using Stata/MP v. 13 ©.
Results
Of the overall insured population in 2006 (annual aver-
age, 980,463 workers), about 45 % of men and 28 % of 
women underwent a medical evaluation for a total sam-
ple of 372,370 individuals (72 % men). In both sexes, the 
most prevalent age group was the 25–34 year group [mean, 
35.9 years (SD 9.8) for women; 37.9 years (SD 11.2) for 
men], confirming the generally young age distribution. 
Administrative and skilled manual were the most prevalent 
occupational social classes for women and men, respec-
tively. Hyperlipidemia and hypertension were the most 
prevalent chronic conditions, and men were more likely to 
be overweight or obese. Regarding health behaviors, 44 % 
of men and 37 % of women were current smokers, and 
53 % of women and 28 % of men reported consuming no 
alcohol (Web Appendix 1). The total symptom prevalence 
was 14 % for men and 26 % for women; of these, sleep dis-
turbances at night (42 vs 40 %), fatigue (10 vs 17 %), low 
back pain (13 vs 9 %), and neck pain (6 vs 12 %) were the 
most common, in addition to headache for women (4.6 %) 
(Web Appendix 2).
From the MCA analysis, for both men (n = 222,506) 
and women (n = 84,113) with at least one health condition, 
we obtained two dimensions that explained 83 and 77 % of 
the total variability, respectively. The first dimension (D1) 
was related to cardiovascular conditions and health behav-
iors, and the second (D2) included symptoms. In men, D1 
(65 % of inertia) was composed of the following categories: 
hyperlipidemia, hypertension, diabetes, coronary artery 
disease, obesity, and being a former smoker. In women, 
D1 (49 % of inertia) included venous thrombosis, coronary 
artery disease, cerebrovascular disease, and peripheral vas-
cular disease. In men, D2 (18 % of inertia) included head-
ache, neck, and low back pain, and in women, D2 (28 % of 
inertia) included these same symptoms, in addition to sleep 
disruption at night (Table 1). While only relevant catego-
ries from the MCA results are shown in Table 1, the non-
significant categories are listed in the table footnote. As 
previously mentioned, relative contributions reflect how 
well categories are represented in a dimension (i.e., values 
closer to 1 indicate a better representation of the category 
within a dimension) taking into account a given variable is 
considered well represented in a dimension if the relative 
contribution of the variable is not <0.6 (or 60 %), or analo-
gously, its categories’ relative contribution is at least 0.3 (or 
30 %) (Greenacre 1984).
Table 2 shows the distribution of the MDMS according 
to three different groups: based solely on chronic condi-
tions, chronic conditions plus symptoms, or chronic condi-
tions plus both symptoms and habits. For both sexes, the 
Baseline sample
(Medical evaluation) 
Men = 269,083 (72.4%) 
Women = 103,287 (27.6%)
Sample for SA incidence
Men = 236,500 (87.9%) 
Women =91,440  (88.6%)†
Excluded, not eligible*
Men = 18,789 (7.0%) 
Women =7,049 (6.7%)†
Excluded, missing key variables
Men =13,794 (5.1%) 
Women = 4,798 (4.7%)†
Fig. 1  Flowchart of sample selection. *Persons whose coverage by 
the mutual insurance company ended prior to the 2006 medical evalu-
ation or before a recorded SA episode, and those who were on SA 
leave during the medical evaluation. †Percentage refers to the figures 
showed in the preceding box
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proportion of individuals identified as having morbidity or 
multimorbidity was greater, and mean scores by number 
of conditions lower, when all three health conditions were 
used. In this latter group, 40 % of men and 15 % of women 
reported at least one of these conditions.
Among individuals with multimorbidity (12 % of men; 
2 % of women), the overall mean score was 33 (SD 16) for 
men and 28 (SD 11) for women. Half of men and women 
showed a score lower than 29 and 25, respectively (Table 3).
The final analytical sample used in the Cox models 
showed no significant differences across MDMS levels 
with those excluded from analysis (men, p = 0.11; women, 
p = 0.84). In both sexes, both prior SA episodes and an 
increasing number of health conditions were associated with 
a greater risk of SA incidence. A trend toward higher risk of 
new SA episodes was observed among men as MDMS lev-
els increased; from HRa = 1.04 (95 % CI 1.01–1.08) when 
there was one health condition present to HRa = 1.20 (95 % 
CI 1.12–1.28) at high MDMS levels. Women showed a sim-
ilar trend, although the HRa values did not reach statistical 
significance. When stratified by prior SA episodes and other 
covariates, this effect persisted (Table 4).
Discussion
We created a new multidimensional multimorbidity score 
(i.e., the MDMS), using a methodology that allows us to 
Table 1  Multiple correspondence analysis (MCA) results according to the contributing variables
a Men with any of health conditions included in the MCA. Nonsignificant conditions: venous thrombosis, cerebrovascular disease, peripheral 
vascular disease, fatigue, alcohol consumption, sleep disturbances
b Women with any of health conditions included in the MCA. Nonsignificant conditions: hypertension, hyperlipidemia, diabetes, BMI, fatigue, 
tobacco and alcohol consumption









Men (n = 222,506)a 0.830
 Dimension 1 0.650
  Hyperlipidemia 0.114 0.186 0.972 0.09 0.171
  Hypertension 0.184 0.297 0.975 0.15 0.278
  Diabetes 0.056 0.083 0.936 0.04 0.081
  Coronary artery 
disease
0.055 0.072 0.855 0.04 0.072
  Obesity 
(BMI > 30)
0.047 0.131 0.897 0.03 0.065
  Former smoker 0.058 0.100 0.887 0.03 0.079
 Dimension 2 0.180
  Headache 0.015 0.072 0.877 0.04 0.072
  Low back pain 0.063 0.344 0.951 0.17 0.338




 Dimension 1 0.490
  Venous thrombosis 0.078 0.144 0.909 0.07 0.140
  Coronary artery 
disease
0.081 0.154 0.936 0.08 0.154
  Cerebrovascular 
disease
0.090 0.161 0.884 0.08 0.161
  Peripheral vascu-
lar disease
0.174 0.305 0.862 0.15 0.305
 Dimension 2 0.280
  Headache 0.028 0.084 0.846 0.04 0.084
  Low back pain 0.110 0.332 0.856 0.17 0.332
  Neck pain 0.112 0.347 0.860 0.17 0.337
  Sleep disturbances 0.034 0.069 0.569 0.02 0.046
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combine chronic health conditions, health-related behav-
iors, and selected chronic symptoms. In contrast to previ-
ously developed multimorbidity measures which have been 
aimed to older and, typically, less healthy populations, our 
MDMS is more suitable for use in younger, and presum-
ably healthier, working populations. We also found that the 
higher the multimorbidity score, the higher the risk of future 
SA episodes. This initial evaluation of its predictive ability 
suggests it can help identify people at risk, and thus prevent, 
delay, and/or mitigate the onset of future health conditions.
Regarding the composition of our MDMS, our findings 
revealed clinically logical relationships along two dimen-
sions that may help inform the burden and distribution of 
multimorbidity beginning at an earlier point in adult life. 
The first dimension was conformed of highly related car-
diovascular risk factors and health behaviors (seven in men 
and four in women). The second dimension grouped pain 
symptoms (i.e., in headache, neck, and back) and sleep 
disturbances, which are often associated with decreased 
self-perceived and mental health (Pikó et al. 1997; Ohayon 
2002).
These results are in overall agreement with prior 
research on multimorbidity patterns in both working and 
patient populations (Holden et al. 2011; Prados-Torres et al. 
2012). In older veteran primary care patients, a “metabolic” 
cluster was identified as being both the most prevalent and 
the one having the highest degree of relationship (Cornell 
et al. 2009); Similarly, both cardiovascular and chronic pain 
morbidity were identified as the most prevalent domains in 
primary care settings (Britt et al. 2008); Cardiovascular dis-
eases, metabolic conditions and osteoarthritis are among 
the six most prevalent diseases within multimorbidity pat-
terns (Violan et al. 2014). In an older German population, 
chronic low back pain and depression had the strongest 
association in clustering with other diseases (Schäfer et al. 
2014); Moreover, mental health and musculoskeletal disor-
ders tend to cluster together with pain symptoms, whereas 
substance and alcohol abuse cluster with both cardiovascu-
lar disease and mental health disorders (Prados-Torres et al. 
2014), and a pain-related cluster, including migraine, neck, 
back, and other pains, was recently described in a working 
population (Holden et al. 2011). Although pain symptoms 
were available in our study, data on mental or musculo-
skeletal diseases were not and alcohol consumption did not 
load into any cluster, but this has already been reported by 
others (Holden et al. 2011).
Previous studies of multimorbidity usually define it as 
the co-occurrence of two or more diseases, without includ-
ing behavioral risk factors or chronic symptoms that, as 
pointed out above, tend to naturally cluster with diseases. 
Table 2  Distribution 
of the multidimensional 
multimorbidity score (MDMS) 
by type and number of health 
conditions included
a Men: hyperlipidemia, hypertension, diabetes, coronary artery disease, obesity, former smoker, headache, 
low back pain, neck pain. Women: venous thrombosis, coronary artery disease, cerebrovascular disease, 
peripheral vascular disease, headache, low back pain, neck pain, sleep disturbances
b Men: hyperlipidemia, hypertension, diabetes, coronary artery disease, obesity, headache, low back pain, 
neck pain. Women: venous thrombosis, coronary artery disease, cerebrovascular disease, peripheral vascu-
lar disease, low back pain, neck pain
c Men: hyperlipidemia, hypertension, venous thrombosis, cerebrovascular disease, peripheral vascular dis-
ease. Women: hypertension, coronary artery disease, peripheral vascular disease
Number Men (n = 269,083) Women (n = 103,287)
Score mean (SD) n (%) Score mean (SD) n (%)
Chronic diseases, symptoms, habitsa
 0 0 (–) 160,905 (59.8) 0 (–) 87,655 (84.9)
 1 11.1 (6.5) 74,824 (27.8) 6.9 (7.1) 13,607 (13.2)
 2 27.1 (11.0) 24,466 (9.1) 26 (9.8) 1671 (1.6)
 >2 50.6 (13.3) 8888 (3.3) 40.5 (9.8) 354 (0.3)
Chronic diseases, symptomsb
 0 0 (–) 188,417 (70) 0 (–) 98,080 (95)
 1 11.7 (8.5) 61,571 (22.9) 27.4 (3.5) 4376 (4.3)
 2 32.6 (10.8) 14,765 (5.5) 55.3 (2.9) 815 (0.8)
 >2 52.8 (10.4) 4330 (1.6) 77.0 (11) 16 (0.1)
Chronic diseasesc
 0 0 (–) 233,548 (86.8) 0 (–) 99,910 (96.8)
 1 39.0 (14.0) 30,171 (11.3) 43.0 (4.2) 3330 (3.3)
 2 39.0 (14.0) 5221 (2) 61.8 (6.4) 39 (0.1)
 >2 81.3 (7.6) 143 (0.1) 100.0 (–) 8 (0.1)
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Thus, our outcome-independent, score-based approach has 
certain advantages, particularly in relation to typical mul-
timorbidity research showing high variability of the mul-
timorbidity prevalence estimates. Besides the contribution 
of methodological aspects (e.g., the type of population 
studied, data availability, sample size, recruitment strategy 
and data collection methods) (Fortin et al. 2012; Salive 
2013), the high variability likely relates to the fact that 
the relative weight of a given chronic condition varies by 
specific outcomes, e.g., mortality or disease severity, lead-
ing to over or underestimation of the effect of some health 
conditions (Fortin et al. 2005). In contrast, and although 
more research is needed to better understand this variabil-
ity, by not focusing on a specific outcome, we obtained a 
multimorbidity measure that can be used subsequently to 
assess its impact on several key health outcomes or target 
populations.
Computing a score may be useful for determining the 
burden and distribution of morbidity in any population of 
interest, and to identify profiles of individuals who might 
need special attention in terms of prevention strategies, 
medical care or health surveillance. Likewise, it may aid in 
projecting healthcare and other economic costs associated 
with populations having these characteristics. Traditionally, 
health care has focused on treatment of single diseases, 
without fully grasping the underlying patterns of coexist-
ing diseases and other chronic conditions. Previous stud-
ies have shown the influence of multimorbidity on a wide 
range of outcomes (Smith et al. 2008; Schäfer et al. 2009; 
Aarts 2012), primarily in populations seeking health care. 
Whether this influence persists in presumably healthier 
persons, such as those in a working population, is less well 
known. Multimorbidity could also impact outcomes more 
relevant to occupational health, such as work ability or 
sickness absence. Thus, for example, we know that dura-
tion of sick leave can vary for a given condition, depending 
on gender, age, and presence of co-existing medical diag-
noses (Ubalde-Lopez et al. 2013). Our multidimensional 
score was more sensitive in detecting a larger proportion of 
workers with single or multiple morbidities than including 
only chronic conditions.
Moreover, the MDMS obtained showed a predictive 
ability to detect an increased risk of incident SA episodes in 
both sexes, even after including prior SA episodes, already 
defined as a strong predictor for future SA, and adjusting 
for other co-variables. In our study, prior SA episodes were 
a strong predictor of future SA, more so than MDMS. This 
is not surprising, given that it is expected a history of SA 
would predict future SA (Roelen et al. 2011). However, the 
predictive effect of MDMS did not disappear after account-
ing for prior SA episodes. In fact, its effect was strongest 
among those without a prior SA episode, especially at high 
levels of MDMS, reflecting the added value of considering 
MDMS as a relevant indicator of future SA.
Although MDMS and incident SA were associated, 
a clear dose–effect relationship was not observed. This 
could be due, for instance, to a “threshold” effect, where 
the greatest association was observed at the highest tertile, 
but not in a stepwise fashion, since the risk for the lower 
tertiles appears to be similar. Further research is needed 
Table 3  Distribution 
of the multidimensional 
multimorbidity score (MDMS) 
among men and women with 
≥2 health conditions
a SD: standard deviation
b P50: median value (50th percentile); P25: 25th percentile; P75: 75th percentile
MDMS Score n (%)
Men (n = 33,354)
 Range 9–100 –
 Mean (SD)a 32.9 (15.5) –
 P50 (P25–P75)b 28 (16–40) –
 MDMS levels [mean (SD)]a
  Low MDMS (first tertile, ≤25 points) 16.8 (2.4) 11,340 (34.0)
  Medium MDMS (second tertile, >25 to ≤38 points) 31.4 (5.0) 11,538 (34.6)
  High MDMS (third tertile, >38 points) 51.7 (9.9) 10,476 (31.4)
Women (n = 2025)
 Range 7–100 –
 Mean (SD)a 28.1 (11.2) –
 P50 (P25–P75)b 24 (21–38) –
 MDMS levels [mean (SD)]a
  Low MDMS (first tertile, ≤22 points) 18.5 (5.8) 908 (44.8)
  Medium MDMS (second tertile, >22 to ≤38 points) 33.3 (6.4) 834 (41.2)
  High MDMS (third tertile, >38 points) 43.8 (7.8) 283 (14.0)
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to better elucidate the dose–response relationship between 
MDMS and SA as well as other outcomes.
To date, morbidity indices have usually been created to pre-
dict specific outcomes (e.g., mortality rates, hospitalization 
indices or physical impairment) by including severity-weighted 
conditions, typically based on the prevalence of selected health 
conditions in a specific population. Being based on a specific 
index-outcome relation they can only, by definition, be assumed 
to have predictive effects on that specific outcome. As such, 
these indices are of limited generalizability. In contrast, our pro-
posed MDM indicator goes beyond simply measuring the pres-
ence of certain health conditions and applying weights based 
on the sample-specific prevalence. The MDMS is based on 
the non-random relationship among health-related conditions, 
available in any population, independent of a pre-specified out-
come. It can therefore be generated in any given population and 
may be useful to test predictive effects on a variety of outcomes.
Regarding the use of MCA in our approach, prior stud-
ies have used different statistical strategies to reduce long 
lists of clinical variables, in order to identify multimorbid-
ity patterns (Britt et al. 2008; Cornell et al. 2009; Holden 
et al. 2011; Prados-Torres et al. 2012). Most have relied 
on factor analysis, which is best used when the variables 
are either continuous or semiquantitative (e.g., Likert-type 
Table 4  Associations (HR) of levels of multidimensional multimorbidity score (MDMS) and number of previous sickness absence (SA) epi-
sodes with total incident SA episodes, during 2 years of follow-up after medical evaluation in 2006, in men and women
a Crude hazard ratio and 95 % confidence interval
b HRa = hazard ratio and 95 % confidence interval adjusted for age and occupational social class
Total Previous SA No previous SA
(n = 236,500) (n = 14,714) (n = 221,786)
Cases HRc (95 % CI)a HRa (95 % CI)b Cases HRa (95 % CI)b Cases HRa (95 % CI)b
Men
 Morbidity 17,193 9998 7195
  No health condition 8749 1.00 1.00 4982 1.00 3767 1.00
  One health condition 5218 1.27 (1.22–1.31) 1.04 (1.01–1.08) 3051 0.98 (0.94–1.03) 2167 1.12 (1.06–1.18)
  ≥2 health conditions
   Low MDMS (first tertile, ≤25 points) 1014 1.62 (1.52–1.73) 1.14 (1.06–1.21) 604 1.01 (0.93–1.10) 410 1.33 (1.2–1.48)
   Medium MDMS (second tertile, >25 to  
≤38 points)
1057 1.65 (1.55–1.76) 1.10 (1.03–1.18) 643 0.99 (0.91–1.08) 414 1.30 (1.17–1.44)
   High MDMS (third tertile, >38 points) 1155 1.98 (1.86–2.11) 1.20 (1.12–1.28) 718 1.07 (0.98–1.16) 437 1.45 (1.31–1.62)
 Previous SA
  No episodes 7195 1 1 – –
  1–4 episodes 9735 1.92 (1.91–1.93) 1.89 (1.87–1.90) – –
  >4 episodes 263 2.20 (2.14–2.25) 2.16 (2.11–2.22) – –
Total Previous SA No previous SA
(n = 91,440) (n = 6303) (n = 87,137)
Cases HRc (95 % CI)a HRa (95 % CI)b Cases HRa (95 % CI)b Cases HRa (95 % CI)b
Women
 Morbidity 7307 4452 2855
  No health condition 5742 1.00 1.00 3407 1.00 2335 1.00
  One health condition 1337 1.54 (1.46–1.64) 1.15 (1.08–1.22) 890 1.11 (1.03–1.19) 447 1.20 (1.09–1.33)
  ≥2 health conditions
   Low MDMS (first tertile, ≤22 points) 108 1.86 (1.54–2.25) 1.17 (0.97–1.42) 75 1.08 (0.86–1.36) 33 1.32 (0.94–1.86)
   Medium MDMS (second tertile, >22 to  
≤38 points)
93 1.73 (1.41–2.13) 1.22 (0.99–1.50) 64 1.14 (0.89–1.46) 29 1.29 (0.89–1.86)
   High MDMS (third tertile, >38 points) 27 1.51 (1.04–2.21) 1.40 (0.96–2.04) 16 1.42 (0.87–2.32) 11 1.38 (0.76–2.49)
 Previous SA
  No episodes 2855 1.00 1.00 – –
  1–4 episodes 4310 1.92 (1.91–1.94) 1.90 (1.88–1.92) – –
  >4 episodes 142 2.33 (2.25–2.41) 2.29 (2.21–2.37) – –
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responses). MCA is better suited to examining relation-
ships among categorical variables, whether nominal or 
discrete, allowing the identification of clusters by reducing 
data dimensions, independently of the outcome. Given that 
all our questionnaire items had categorical responses, using 
MCA was more appropriate, despite having only been used 
sparingly in the study of multimorbidity (García-Olmos 
et al. 2012).
Multimorbidity prevalence by sex has also varied in pre-
vious studies, as it did in our study, depending on the age 
group and target population, with inconsistent findings, 
including no difference or a higher prevalence in either sex. 
In our population, women attended fewer medical evalua-
tions in 2006 than men, which might explain their under-
representation in the study. There are a couple of plausible 
explanations for this. Women, especially in the younger age 
range of a working population, are more likely to get rou-
tine health evaluations through their primary care provider 
or gynecologist, than through a physician selected by a 
health insurance company (Case and Paxson 2005; Carret-
ero et al. 2014). On the other hand, in our study population, 
men were more likely to be employed in manual occupa-
tions, whereas women were in administrative/clerical jobs. 
The nature of occupational risks, therefore, is likely to have 
been different, which may have led to a larger proportion 
of men undergoing what was perceived as a work-related 
health evaluation. Thus, some degree of underestimation 
of multimorbidity prevalence among women in this study 
has to be considered. Nevertheless, our results highlight the 
need to analyze health-related outcomes separately for men 
and women.
Although morbidity is well known to increase with age, 
it is not just an issue of the elderly, but also worth con-
sidering in younger groups, since patterns of risk factors, 
health conditions, and multimorbidity prevalence can vary 
along the life course as well as within age groups (Taylor 
et al. 2010; Prados-Torres et al. 2012). It is reasonable to 
consider multimorbidity as a dynamic phenomenon that 
evolves over time. In both women and men, at early ages, 
there are likely risk factors and behaviors that predispose 
to the development of chronic disease in the middle part of 
life. And in later stages, complications from these diseases 
can take on a dominant role, at a high cost to both indi-
viduals and society. For many cardiovascular and metabolic 
diseases, these patterns are well established, e.g., the effect 
of hypercholesterolemia and smoking in coronary artery 
disease, or obesity in diabetes (Prados-Torres et al. 2012). 
Risk factors are considered the starting point for future 
morbidity, but the decision to include them in multimor-
bidity measures is admittedly controversial (Guthrie et al. 
2012). Although it is unclear whether risk factors impact 
how diseases cluster, a recent study found obesity as a pre-
dictor of multimorbidity to have a role in the clustering 
of chronic conditions (Agborsangaya et al. 2013). The 
expected increase in major risk factors (Vaughan-Jones 
2009), strongly associated with unfavorable health states 
and a higher number of chronic health conditions (Surís 
et al. 2008; WHO 2009), points to the need for their inclu-
sion in the concept of multimorbidity, at least in younger, 
healthier populations. By identifying these at-risk groups 
earlier, interventions could be designed to promote health-
ier habits which could impact future SA, among other 
outcomes.
Our results should be interpreted taking into account 
certain limitations and considerations. First, although our 
study population was highly dominated by men, which 
limits the comparison of multimorbidity profiles between 
sexes, the distribution of this insured group was comparable 
to that of the general Spanish workforce (data not shown). 
Second, given that participation in the 2006 medical evalu-
ation was voluntary, some degree of selection bias may 
have affected our findings. Third, generalization to the non-
working or even the entire working population should be 
done with caution since working populations, such as ours, 
and especially those undergoing a health examination, tend 
to be healthier and possibly more motivated to know their 
health status than the general or other populations (Li and 
Sung 1999; Loeppke et al. 2010). Future research should 
be conducted with different datasets to both replicate our 
findings and provide evidence for the generalizability of the 
proposed MDMS score. However, the working population 
was appropriate for our study aim and our findings are, at 
a minimum, likely to be relevant to other working popula-
tions. Indices of comorbidity, such as the Charlson Index, 
have proven useful as a tool for interventions at the indi-
vidual clinical level (D’Hoore et al. 1996). In contrast, the 
MDMS might be more appropriate for predicting health-
related outcomes at the population level. Although our 
results may have clinical significance, given the early stage 
of our research, it is premature to assert how clinically use-
ful the MDMS would be.
Fourth, our data came from only one public health insur-
ance company, but this was one of the largest in the coun-
try with representation throughout Spain, where healthcare 
coverage is comparable to other western European Union 
countries (Figueras et al. 2008). Fifth, being a working 
population, our participants were relatively younger than 
the overall population, and their morbidities are likely to 
fluctuate over time. Our study design had only a baseline 
measurement of multimorbidity, which precluded examin-
ing temporal changes in the relationship between MDMS 
and SA, which would be better addressed using a repeated 
measures design.
Other limitations relate to the use of questionnaire-based 
self-reported data. The data had been previously collected, 
but were not specifically designed to study multimorbidity. 
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Thus, we may have underestimated the prevalence of health 
conditions, behaviors, and other morbidities beyond those 
included in this study. For example, most of the available 
information centered on cardiovascular factors, and data on 
other common health conditions (e.g., mental, musculoskel-
etal disorders or cancer) were not collected (Diederichs et al. 
2011). The number of health conditions included in previous 
studies of multimorbidity has varied widely (Huntley et al. 
2012) and will always represent a limitation. Nonetheless, by 
including symptoms (e.g., pain and sleep disturbances) as a 
dimension of disease, some of these other pathologies may 
have been indirectly captured. The chronic conditions were 
identified by self-report, but not confirmed clinically (e.g., 
physician diagnosis) (Preen et al. 2004). However, the pre-
dictive accuracy of self-reported morbidity as the basis for an 
index of chronic conditions has been previously validated in 
health interview surveys (Rius et al. 2008).
Finally, we must consider that multimorbidity occurs 
within a multifactorial context determined by individual, 
behavioral, social, cultural, economic, and environmental 
circumstances (Salive 2013). Thus, there are likely to be 
complex interactions underlying the clustering of coexisting 
health conditions that go beyond simple biological factors, 
so a better understanding of the etiology, underlying patho-
genesis and patterns of multimorbidity is key to advancing 
research in this field (Starfield 2011b). The study of mul-
timorbidity is relatively recent, and greater consensus on 
its measurement and interpretation is needed. To enhance 
generalizability, future studies should validate current 
approaches to its measurement, so that it can be applied in 
different settings and populations. In contrast with patient 
and/or older populations, studies on the applicability of mul-
timorbidity indicators to younger and healthier populations 
are scarce. Here we propose what may be a more holistic 
approach to examining multimorbidity, based on calculation 
of a score rather than estimating prevalence, incorporating 
factors not limited to chronic diseases, and applying it ear-
lier in the life course. Although our MDMs ended up includ-
ing conditions that are not only relevant to young but also 
older populations, this does not diminish the potential utility 
of the strategy proposed to create the multimorbidity score.
Next steps will include examining this approach in other 
populations and determining its value by examining the 
degree to which it is able to predict various outcomes. These 
outcomes should not be limited to indicators such as mortality 
or disease severity and their burden on the healthcare system, 
but also include the impact of multimorbidity as a potential 
determinant of ability to work, sick leave, or quality of life.
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